Relationships between tumour necrosis factor, eicosanoids and platelet-activating factor as mediators of endotoxin-induced shock in mice

British Journal of Pharmacology
A K MyersR M Price

Abstract

1. The toxicity of intravenous recombinant human tumour necrosis factor (rhTNF), a TNF fragment (TNF114-130), endotoxin and combinations of rhTNF or TNF114-130 were tested in mice. Neither rhTNF nor TNF114-130 was lethal alone, but when combined with a non-lethal dose of endotoxin, rhTNF provoked dose-dependent mortality, as did higher doses of endotoxin alone. 2. Both the toxicity and the vasopermeability changes induced by endotoxin alone were blocked by the platelet-activating factor (PAF) antagonist BN52021, indomethacin or the dual cyclo-oxygenase/lipoxygenase inhibitor BW755C. 3. The lethality of the combined low dose endotoxin/rhTNF challenge was unaffected by pretreatment with BN52021, indomethacin or BW755C, or by treatment at 6 h intervals with BN52021 or BW755C. 4. The results of these studies suggest that TNF, a putative, early mediator of septic or endotoxin shock, cannot by itself mimic all of the effects of bacterial endotoxin in the model used in this study. Apparently, TNF works synergistically with other mediators whose release is stimulated by endotoxin. 5. The results also suggest that the mechanism of shock production by the rhTNF/endotoxin combination in mice is not dependent on the early stimulation of ei...Continue Reading

References

Jun 15, 1979·Biochemical Pharmacology·G A HiggsJ R Vane
Jan 1, 1985·Journal of Cardiovascular Pharmacology·L S OlanoffP V Halushka
Jun 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·I C KettelhutA L Goldberg
Jun 1, 1988·The Journal of Experimental Medicine·A Waage, T Espevik
May 1, 1988·The Journal of Clinical Investigation·X M Sun, W Hsueh
Jan 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J L Rothstein, H Schreiber
Oct 24, 1986·Science·K J TraceyJ D Albert
Feb 26, 1985·European Journal of Pharmacology·Z TerashitaS Sumida
Jun 1, 1983·British Journal of Pharmacology·A MyersP Ramwell
Dec 31, 1982·Biochemical and Biophysical Research Communications·E LanaraC A Demopoulos

❮ Previous
Next ❯

Citations

May 1, 2010·Molecular Neurobiology·Salomon Esquenazi, Haydee E P Bazan
Jul 1, 1995·International Journal of Immunopharmacology·T R DownsJ F French
Jan 1, 1993·International Journal of Antimicrobial Agents·S Q DejoyS S Kerwar
Jun 1, 1993·Annals of Surgery·J R FletcherC B Rodning
Jul 1, 1997·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·C A TerreginoG J Slotman
Jul 19, 2000·Infection and Immunity·G D JacksonW A Sewell
Feb 1, 1995·Postgraduate Medical Journal·E A Fagan, M Singer
Oct 31, 2002·American Journal of Respiratory and Critical Care Medicine·Peter Q EichackerCharles Natanson
Sep 6, 2014·Nature Reviews. Drug Discovery·Mitchell P Fink, H Shaw Warren
Jan 5, 2002·Expert Opinion on Investigational Drugs·R L Añel, A Kumar
Sep 13, 2015·Regulatory Toxicology and Pharmacology : RTP·Jeffrey W CardTeresa L Wright
Nov 1, 1991·The Journal of Surgical Research·C S Rock, S F Lowry
Sep 12, 2013·Virulence·Mitchell P Fink
Sep 1, 1995·The British Veterinary Journal·N C OlsonJ R Dodam

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.